Naloxone Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01183 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | opiate dependence | DL |
| 2 | morphine dependence | DL |
| 3 | substance abuse/dependence | DL |
| 4 | continuous spikes and waves during sleep | KG + DL |
| 5 | lissencephaly with cerebellar hypoplasia | KG + DL |
| 6 | progressive encephalopathy with leukodystrophy due to DECR deficiency | KG + DL |
| 7 | schizophreniform disorder | KG + DL |
| 8 | nasal cavity disease | KG + DL |
| 9 | psychotic disorder | KG + DL |
| 10 | hypoglycemia | KG + DL |
| 11 | acute pulmonary heart disease | KG + DL |
| 12 | drug-induced dyskinesia | KG + DL |
| 13 | acute laryngopharyngitis | KG + DL |
| 14 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 15 | primitive portal vein thrombosis | KG + DL |
| 16 | hepatoportal sclerosis | KG + DL |
| 17 | idiopathic copper-associated cirrhosis | KG + DL |
| 18 | hepatopulmonary syndrome | KG + DL |
| 19 | acute intermittent porphyria | KG + DL |
| 20 | congestive heart failure | KG + DL |
| 21 | pharyngitis | KG + DL |
| 22 | primary hereditary glaucoma | KG + DL |
| 23 | treatment-refractory schizophrenia | KG + DL |
| 24 | open-angle glaucoma | KG + DL |
| 25 | lingual-facial-buccal dyskinesia | KG + DL |
| 26 | chronic tic disorder | KG + DL |
| 27 | early-onset schizophrenia | KG + DL |
| 28 | substance withdrawal syndrome | KG + DL |
| 29 | HIV infectious disease | KG + DL |
| 30 | benign shuddering attacks | KG + DL |
| 31 | extrapyramidal and movement disease | KG + DL |
| 32 | mental disorder | KG + DL |
| 33 | hepatic porphyria | KG + DL |
| 34 | feline acquired immunodeficiency syndrome | KG + DL |
| 35 | simian immunodeficiency virus infection | KG + DL |
| 36 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 37 | parkinsonian disorder | KG + DL |
| 38 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 39 | psychogenic movement disorders | KG + DL |
| 40 | diaphanospondylodysostosis | KG + DL |
| 41 | primary orthostatic tremor | KG + DL |
| 42 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 43 | commissural lip fistula | KG + DL |
| 44 | osteoradionecrosis of the mandible | KG + DL |
| 45 | oral leukoedema | KG + DL |
| 46 | burning mouth syndrome | KG + DL |
| 47 | drug/alcohol-induced mental disorder | KG + DL |
| 48 | corneal pigmentation | KG + DL |
| 49 | obsolete rare pulmonary disease | KG + DL |
| 50 | skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.